Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
52gk94t0FSn4PFYY
